Category: Company News

CHARLOTTETOWN, PRINCE EDWARD ISLAND, CANADA, April 1, 2021 /EINPresswire.com/ — iWave, the industry’s leading fundraising intelligence platform, today announced its position again as the #1 highest rated solution in the Leader quadrant in G2’s Spring 2021 Grid^® Report and the top spot in the G2 Momentum Grid for Donor Prospect Research. Leaders are determined by their high levels of customer satisfaction and likeliness to recommend ratings from real users on G2, the world’s leading business solutions review website.

iWave’s commitment to customer satisfaction and success is reflected by the nonprofit industry and its members. Based on real-time user reviews by nonprofit professionals who work in fundraising and prospect development, iWave received the highest Satisfaction Score among solutions in Donor Prospect Research. This is the 40th award that iWave has received from G2.

With over 200 reviews, iWave outperformed all other fundraising intelligence and prospect research solutions with a score of 95 in overall satisfaction outranking DonorSearch at 79 and WealthEngine at 69, clearly ranking it the best and easiest to use fundraising solution available to nonprofit organizations.

iWave also led the G2 Momentum Grid Report with a Momentum Grid Score of 81, outperforming DonorSearch at 66 and WealthEngine at 39. The G2 Momentum score is a reflection of employee growth, reviews, social, web growth, and year-over-year change.

“Once again it is a great honor and achievement to have received this positive feedback and recognition from the nonprofit community,” said iWave President and CEO Ross Beattie. “We care about our clients’ missions and that is what ultimately drives our behavior and authentic desire to do the best we possibly can for our clients. We continue to invest in product innovation and client experience to help ensure our clients’ success and please stay tuned for more exciting innovation announcements over the next few months.”

“The User Experience is our central focus. We constantly strive to exceed expectations by being responsive to the users’ needs and questions,” said iWave Director of Client Success, Penny Rennie. “With dedicated, Client Success Managers, our customers have a champion and trusted advisor to help attain their fundraising goals.”

What Real Users Say About iWave

“The iWave Team are friendly and work to make sure that the user has the best use of the product. The RelSci connection is of high interest for our organization and the ability to search for specific positions within a company.”

“The new iWave layout is user friendly and appealing! Having all data on one single page is good to work with. All the donor profiles that I created as a user, having it in one place as my own database helps me to keep track of my work too. Overall saves time and improves your work efficiency. Once you get to know what to look for in iWave everything is easy.”

“iWave has the most comprehensive, easy to use wealth prospecting information on the market. From the 360 review for individuals to the foundation and corporate modules, everything is there. They assemble so much information and then compile it into a fairly easy to use review system. Even when I’ve left organizations and moved on, I usually go back to iWave and bring them onboard as my preferred wealth engine provider. Also, the customer service and support is always prompt, friendly, helpful and outstanding. The people that work on their team are really wonderful.”

“It’s comprehensive in both breadth and depth of information. It makes research very efficient for shops with only one researcher.”

About G2

Headquartered in Chicago, G2 is revolutionizing the way businesses discover, buy and manage software and services. More than three million users per month rely on G2 to help them find and buy the best software for their businesses. The platform has more than a million verified reviews and $100M in total funding invested by IVP, Accel Partners, LinkedIn, Emergence Capital, Pritzker Group, Chicago Ventures, Hyde Park Ventures, industry leaders and founders. G2’s customers include Amazon Web Services (AWS), IBM and Zoom and Its most recent funding, a $55M Series C, was announced in October, closely followed by the company’s acquisitions of Siftery and Advocately.

About iWave

iWave, the industry’s top-rated fundraising intelligence platform, enables nonprofit organizations to fundraise with confidence. In a new era of nonprofit fundraising, iWave solves critical challenges facing fundraising professionals today: how to identify, qualify and retain donors to raise more major gifts. iWave’s intuitive and easy-to-use solutions give access to the industry’s highest quality wealth and philanthropic information so you can determine who to ask, how much to ask for, and when to ask. Since 1991, over 6000 clients, including many of the largest education, healthcare and nonprofit organizations in the world, have relied on iWave to power their fundraising efforts.

Visit our website and blog, follow us on Twitter, Instagram and LinkedIn and like us on Facebook.

Dana Prestigiacomo
iWave
1 800-655-7729
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Sunnyvale, California, March 25, 2021 – Gener8 LLC, a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, announced today the placement of Jerry Jurkiewicz as Chief Executive Officer. This appointment helps position Gener8 for continued capability and geographic expansion as a leader in its industry. During the past year Gener8 also completed the acquisition of Symbient Product Development to extend its engineering capabilities beyond its core focus on advanced instrumentation into companion consumable devices, offering customers a complete turnkey instrument and consumable solution for their engineering and manufacturing needs, particularly in point-of-care diagnostics and drug delivery markets.

Mr. Jurkiewicz comes to Gener8 with a broad array of leadership experience in the life sciences, medical device, analytical instrument, test & measurement, and industrial segments. He began his career at Ford Motor Company and Allied Signal, where he developed expertise in operational excellence. He was hired as PerkinElmer’s first Vice President of Global Operations in Optoelectronics in 2001, quickly rising to lead the division as General Manager. Later, he served as President of IDEX Corporation’s Optics & Photonics business unit, overseeing 800 employees across 12 sites in the U.S., Europe and Asia.  Most recently, as the Chief Executive Officer of Orchid Orthopedic Solutions, a PE-backed orthopedic implant and instrument contract manufacturer, he was successful in integrating transact accretive add-on acquisitions.

“We are fortunate to have someone of Jerry’s caliber and experience to lead Gener8. We are in the midst of transformative growth at Gener8, coming off strong 2020 performance, and the addition of Jerry to a company that had already shown the ability to grow at rates that outpace the industry in which it participates will be immensely valuable as we successfully implement our strategy and continue to improve ability to compete and deliver breakthrough technologies,” said Dave Finley, a Managing Partner at Sverica Capital Management and Chairman of the Gener8 Board of Directors. “Jerry is extremely well-suited for this position.  He is a proven leader and an experienced CEO uniquely positioned to lead Gener8’s continued ascension to that of the industry leader.”

David Klein, founder of Gener8 stated, “I am excited to have Jerry join Gener8 as the CEO and lead the company going forward. I am very proud of the team at Gener8 and what they have accomplished.  Jerry is an excellent addition to that team and will make an incredible impact on Gener8. I look forward to working together with Jerry on the journey ahead.”

“I am excited and honored to join the team at Gener8 and to help lead our collective growth efforts. I have deep respect for all the work that has taken place at Gener8, and I look forward to working closely with the board, members of the management team, and team members,” adds Mr. Jurkiewicz. “Together, we will mark a new path for growth for Gener8.”

About Gener8

Gener8, founded in 2002, offers full product lifecycle engineering and manufacturing for complex instruments and products within the highly regulated life sciences and medical device markets. The services that Gener8 provides allow for an agile and fast time to market solution that results in high reliability solutions for customers. With locations in Sunnyvale, CA, San Diego, CA and Boston, MA, Gener8 operates in the corridors of innovation and maintains all industry specific certifications. For more information, please visit www.gener8.net.

About Sverica Capital Management

Sverica Capital Management is a leading growth-oriented private equity firm that has raised over $1.1 billion across five funds. The firm acquires, invests in and actively builds companies that are, or could become, leaders in their industries. Since inception, Sverica has followed a “business builder” approach to investing and takes an active supporting role in its portfolio companies. Sverica devotes significant time and internal resources to help its management teams develop and execute growth strategies and proactively looks for levers to pull to accelerate growth by reinvesting back into those companies. Sverica firmly believes in building businesses collaboratively that can endure for the long term by starting with a strong foundation and bringing the right people and playbook to drive reinvestment and ultimately strong returns for our investors. For more information, please visit sverica.com.

Women’s Health USA, a national leader in value-based care and practice management services for the women’s health sector, announced today two executive appointments with vital roles in the company’s mission to grow thriving practices and improve health, together. Angela Briggs-Paige has joined the company as Senior Vice President, People & Culture, and Sara Eversden has joined as Regional Vice President and is currently serving as the CEO for Women’s Health Texas.

“We are delighted to welcome Angela and Sara to Women’s Health USA as we continue to enrich our culture and grow our presence in key states such as Texas by providing women with the highest-quality integrated healthcare that meets their needs,” said Gregg Osenkowski, Director for Women’s Health USA Board and Partner of Sverica Capital Management. “As a seasoned HR leader, Angela understands the value and importance of ensuring teammates are fulfilled in order to advance our mission of supporting our physicians across the country. Sara, a proven healthcare executive, has the unique expertise of finance and operations that will chart the path for Women’s Health Texas and lead our ongoing growth as a premier women’s health provider.”

Angela Briggs-Paige

Angela joins Women’s Health USA with more than 20 years of experience in cultural transformation and in the recruitment, retention, and development of talent that delivers business results. Prior to joining Women’s Health USA, Angela provided strategic oversight and leadership of all people operations including HR technology, service delivery, operational effectiveness, business process review, continuous improvement activities, technology strategy, and staff coaching and development within the communication and healthcare industries.

In her new role with Women’s Health USA, Angela leads People & Culture, where she is responsible for developing and directing critical initiatives within these important areas. Angela is a certified senior HR professional and holds an MBA from Western Governors University with a concentration in Management and Strategy.

Sara Eversden

Sara brings more than 25 years of operational, financial and executive experience aligning organizations on strategic initiatives, providing governance and structure, and ensuring financial goals are successfully achieved. Prior to joining Women’s Health USA, Sara led the development and implementation of financial operations to support physician practice management and operational teams. She has a passion for designing and building infrastructure for healthcare organizations and understands the value of strong strategic partnerships with health insurance companies to drive population health objectives and ultimately, patient care.

Sara serves as Regional Vice President for Women’s Health USA with a focus on growing the Texas region. She is a Certified Public Accountant and holds a Master of Health Administration from University of Iowa.

Angela and Sara bring exceptional expertise and experience from their respective fields that will continue driving quality healthcare for patients and support for our physicians in more communities across the country.

About Women’s Health USA

Women’s Health USA is a provider of value-based care and practice management services to more than 600 women’s health providers across the U.S. With a unique focus on women, Women’s Health USA is an influential player in the development of new cost effective, value-based modes of care delivery. For 22 years, the company has successfully implemented innovative growth strategies and driven streamlined operational costs, payer alignment, ancillary services development, brand development strategies and risk management services. Its unique partnership model enables women’s health groups to operate independently, while leveraging the resources and influence of a national organization. If you would like more information about this, please contact Leslie Stedman at 860.678.3400 or lstedman@whusa.com.

SUNNYVALE, Calif., Feb. 26, 2020 /PRNewswire/ — Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), announced today that it has completed its acquisition of Symbient Product Development, LLC (“Symbient”), a leading provider of design engineering for polymer life sciences consumables, based in Carlsbad, California.

With the acquisition of Symbient, Gener8 will expand beyond its core focus on advanced instrumentation to add companion consumable devices and will now offer customers a complete turnkey instrument and consumable solution for their engineering and manufacturing needs. In addition to long-standing core competencies in design engineering, rapid prototype mold fabrication and injection molding, Symbient has developed assembly capabilities to facilitate low-to-medium volume manufacturing. Combined with its deep expertise in materials science and fluid dynamics, Symbient has emerged as a key player in the point-of-care diagnostics and drug delivery markets.

“The team at Symbient has built a tremendous business, taking on high complexity engineering projects with best-in-class turnaround times,” said David Brakenwagen, Gener8 CEO. “We are already collaborating on a number of customer programs which are yielding great success and are excited to provide this differentiated end market solution with the decades of combined technology, know-how and experience.”

“Symbient’s focus has always been on meeting our customers’ needs – top-flight engineering, quality product, fast turnaround time. We saw a likeminded partner in Gener8 on the instrument side and look forward to the additional resources and synergies to provide solutions to our customers on a larger scale,” added Scott Castanon, Founder and CEO of Symbient.

Alira Health served as a strategic advisor to Gener8 on the transaction.

About Gener8

Gener8, founded in 2002, offers full product lifecycle engineering and manufacturing for highly complex instruments and products within the highly regulated Life Sciences and Medical Device markets. The services that Gener8 provides allow for an agile and fast time to market solution that results in high reliability solutions for customers. With locations in Sunnyvale, CA and Boston, MA Gener8 operates in the corridors of innovation and maintains all industry specific certifications. For more information, please visit www.gener8.net.

About Sverica Capital Management

Sverica Capital Management is a leading growth-oriented private equity firm that has raised over $1.1 billion across five funds. The firm acquires, invests in and actively builds companies that are, or could become, leaders in their industries. Since inception, Sverica has followed a “business builder” approach to investing and takes an active supporting role in its portfolio companies. Sverica devotes significant time and internal resources to help its management teams develop and execute growth strategies and proactively looks for levers to pull to accelerate growth by reinvesting back into those companies. Sverica firmly believes in building businesses collaboratively that can endure for the long term by starting with a strong foundation and bringing the right people and playbook to drive reinvestment and ultimately strong returns for our investors. For more information, please visit sverica.com.

iWave, the industry’s top-rated fundraising intelligence solution, announced today the availability of its newest feature, Multi-Lens Scoring. This revolutionary feature has never been seen before in the nonprofit industry and it furthers iWave’s leadership in the fundraising intelligence space. With it, nonprofits can easily and quickly view their donors from completely different perspectives to help them maximize fundraising goals. 

Our industry-first fundraising feature elevates customization to new heights

Nonprofit organizations can fully customize their fundraising experience in iWave based on their unique donors, missions, and goals. To understand how valuable this new feature can be, it’s important to know how iWave scores prospects. iWave is the only solution that uses affinity scores to provide a holistic view of a donor. We believe a donor’s giving interest is crucial to knowing how they will give to you. iWave’s customizable scoring preferences for capacity, propensity and affinity provide the foundation for Multi-Lens Scoring. With this new feature, you can now customize your searches based on even more personal data for a complete, well-rounded donor search. 

You can use Multi-Lens Scoring to:

• Find your TOP prospects who care about your mission
• Sort and cultivate donors into groups that help you reach your GOALS, faster
• Cut your research time by seeing MORE information in a comprehensive way
• Find donors in places you’ve NEVER looked before
• Be ahead of the curve and ready to ADAPT to any organization or campaign changes

Using affinity to your fullest advantage – a new perspective

As an example, a hospital may have a capital campaign to raise funds for an Arts Therapy Facility. Within iWave’s settings, the hospital is able to select Healthcare as the primary affinity (giving interest) to find donors that have donated to healthcare organizations in the past and have a high capacity and history of giving. Thanks to Multi-Lens Scoring, the customization doesn’t stop here. 

Now the hospital can set up another lens by selecting Arts and Culture as the primary affinity. Under this view, they will uncover prospects that have a track record of donating to arts and culture causes or those who are an executive or a board member at an arts and culture organization. 

Then they can segment top prospects into two lists based on their affinity and look at them side-by-side. The fundraising team can then engage with each group using tailored messaging that focuses on their giving interest in either healthcare or arts and culture. 

“Multi-lens screening makes it possible to change the results of your data set depending on the precise propensity, affinity, and giving capacity your organization needs to support each team and each project. From annual fund to membership to major and principal giving, multi-lens screening pinpoints the prospects you should reach out to now. I cannot wait to work with our clients to help them take advantage of this powerful new feature.” (Erin Lynch Moran, Partner, The Solas Group)

Change the game with 5 unique lenses

 Ultimately, this innovative new feature means even more customization for your fundraising efforts. With 5 lenses to try, fundraisers can compare and contrast results, put together multiple lists to work through, and broaden horizons to new potential projects and donor segments.

“We pride ourselves in providing innovations quickly that will have an impact on your organization even more rapidly. We knew our clients needed something to set them apart and fundraise more effectively. Sometimes, it’s about taking a step back and looking at things differently,” said Mary Cote, VP Product, iWave.

This new feature is part of iWave’s cloud-native platform, utilizing AI that boasts a fresh modern design and intuitive layout. The platform is faster, more powerful, and more scalable than before, allowing new enhancements and functionality to be added quickly and easily.

“At iWave, we pride ourselves on being at the forefront of nonprofit fundraising innovation with an agile development process that leverages client and industry insights to continuously bring more value, along with the best customer service in the industry to our nonprofits, higher education, and healthcare organizations. We know we’re changing the game with this new feature and we are excited to see how our clients can succeed and do more for their communities with our help”, said iWave President and CEO Ross Beattie.

Check out our latest blog post on this exciting new feature here.

About iWave

iWave, the industry’s top-rated fundraising intelligence solution, enables nonprofit organizations to fundraise with confidence. In a new era of nonprofit fundraising, iWave solves critical challenges facing fundraising professionals today: how to identify, qualify and retain donors to raise more major gifts. iWave’s intuitive and easy-to-use solutions give access to the industry’s highest quality wealth and philanthropic information so you can determine who to ask, how much to ask for, and when to ask. Since 1991, over 6000 clients, including many of the largest education, healthcare and nonprofit organizations in the World, have relied on iWave to power their fundraising efforts. Visit our website and blog, follow us on Twitter and LinkedIn and like us on Facebook and Instagram.

We’re excited to announce that Gorilla Logic has been highlighted as a top app development partner on the Clutch 1000 for creating state-of-the-art apps for our clients. Clutch is a verified market research firm and the Clutch 1000 features the top-performing firms on their site.

We couldn’t have earned this award without our wonderful clients. As part of the research process, they were asked to provide feedback on our performance. Take a look at some of the kind words they had to share below: 

“Their personality and enthusiasm distinguish them from other providers. Based on the quality of developers they’ve brought to us, they are big fish in a small pond in Costa Rica. They are the place that all of the developers and talent in Costa Rica want to be and work, so they have a really large talent pool to draw from. They’re getting the cream of the crop in that location.” 

– Product Manager, Gaia, Inc.

“They are able to integrate very well with our teams and work the same hours because they’re in the same time zone. That is the biggest advantage I have with them in contrast to other offshore vendors I’ve worked with. I consider them to be part of our team.”  

– Director of Quality Engineering, Mersive

“From my experience with other outsourced companies, the developers and other team members from Gorilla Logic have been more dependable and more a part of our team than any I have had experience with before. Not only are they really solid engineers, but they make an effort to fit in and become part of your team as much as the in-house developers, which makes them incredibly easy to work with.”

– Director of Engineering, Weedmaps

We’re honored to be highlighted by Clutch as a top app development partner. Interested in learning how Gorilla Logic can help your business thrive in 2021? Get in touch with us today!

When the Covid-19 pandemic hit, many companies found themselves in a unique predicament.  Their workforce logistics were upended, leading teams to forgo hiring new talent to assist on critical projects. Technology professionals, in particular, had to be creative with their team deployment and strategies. 

Companies needed a partner, but without the cumbersome constraints of hiring an entire internal team. At the same time, offshoring functions to far off countries became questionable as supply chains were disrupted across the board. Gorilla Logic, a Denver-based provider of custom software who provides web application and mobile development, DevOps, UX/UI Design, and more, was already a long time advocate for nearshoring. With the advent of Covid-19, they were well-positioned to swoop in and help. 

What is nearshoring?

“Nearshoring,” unlike offshoring, allows companies to outsource business and software development processes to resources in a nearby country versus across the globe. 

Many companies found it easy to partner with their “nearshore” remote teams since they are highly trained, share the same language, and operate within the same workday. Traditional offshoring includes working with teams located in India and China, where timezones vary and significant language barriers may exist. Nearshoring centers located in Costa Rica and Colombia include professionals who speak fluent English and operate within the time zone of most U.S.-based companies. These individuals are educated, collaborative, and operate as integral team members rather than a faceless entity.  

What do the most effective companies have in common?

To be most effective, Gartner recommends companies share at least four hours of overlap between teams, which nearshoring allows. The most successful companies also implemented a “value algorithm,” a calculation that considers the budgeted dollars per hour and weighs them against team workflows, efficacy, and potential financial constraints.

Beyond their nearshoring success, one of the most significant observations Gorilla Logic made this year is how an increased prioritization on quality and customization has become the driving force in software development – something they expect to last well into 2021. The pandemic primarily drove this renewed focus on a superior digital customer experience informed by Behavior Driven Development (BDD).

The rise of ‘Behavior Driven Development.’

In 2020, Software development teams primarily used BDD to create simple scenarios that describe how an application or product should behave from the customer’s perspective. BDD encourages collaboration between the technical and business stakeholders, ensuring everyone has a clear, shared understanding of the final product’s intended user experience. 

Outside of the tech industry, “customer-focused creation” functions as a similar concept brand use to develop products and services that resonate with their audience. In 2020, consumers spent more time at home and online, allowing for more opportunities to vet products and brands. Companies like Gorilla Logic that thought about the consumer first were most profitable. 

Agile methodology, where solutions evolve through collaboration between cross-functional teams, also played a significant role in determining software development partners’ efficacy in 2020. Within agile methodology, transparency and flexibility are paramount, and teams band together to execute “sprints” to complete multi-step tasks. Instead of getting bogged down or distracted by project obstacles, an assigned team member mitigates potential threats and manages the timeline. Teams continually evaluate results, thus building a natural mechanism for change.

As a new year begins, business leaders face the unique challenge of deciding whether to implement “what worked” during 2020. Applying strategic tactics such as utilizing the nearshoring talent and behavior-driven development, both informed by agile methodologies, will lead brands to evolve further and meet new challenges in 2021.

Adds photochemical machining, metal forming and sensor technology for minimally invasive surgical devices.

NASHUA, NH, November 03, 2020 — Resonetics announced today that it has acquired the medical business of Hutchinson Technology, Inc. (HTI). The HTI Medical business, based in Hutchinson, Minnesota, has developed a number of proprietary manufacturing processes to fabricate and assemble tight tolerance, metal components for market-leading devices used to seal vessels in many types of surgery. The company has industry-leading processes to chemically etch blades, create ceramic features on metal substrates and to fabricate miniaturized electromechanical sensors. These sensors may be used in conventional and robotic surgery and with automated devices to provide real-time feedback to surgeons as well as to authenticate proper setup and utilization in the surgical suite.

“We’re excited to add an array of innovative manufacturing processes developed over decades at HTI

Medical” said Tom Burns, President & CEO of Resonetics. “These processes improve product performance while also reducing manufacturing costs. Looking forward, the ability to integrate mechanical and electronic components in a miniaturized package will enable our customers to broaden adoption of exciting new automated devices and advance surgical robotics to enhance precision, reduce human error, and improve patient outcomes.” Resonetics has signed a long-term lease for 130,000 square feet in the Hutchinson, MN facility and will gain a tenured staff of nearly 150 engineers, technicians and skilled associates.

About Resonetics

Founded in 1987, Resonetics is a pioneer in micro manufacturing and provides contract manufacturing services to the life sciences industry. Resonetics is a leader in laser processing, centerless grinding, nitinol processing, thin-wall stainless steel tubing fabrication, precious metal forming, and other critical machining services. With seven Lightspeed Application Development Labs located strategically to serve MedTech companies around the world, Resonetics is built on a foundation of quality, speed and innovation to deliver best-in-class value with a customer centric approach. The company is ISO 13485:2016 certified with facilities in the United States, Costa Rica, Israel and Switzerland. Resonetics is owned by Regatta Medical, a portfolio company of GTCR. Learn more at www.resonetics.com

Women’s Health USA, a leading management services company in the women’s health sector in the United States, announced today a joint venture partnership with Las Vegas-based Women’s Health Associates of Southern Nevada (WHASN), one of the pre-eminent ObGyn groups in Nevada. In this joint venture, Women’s Health USA and WHASN will work together to design and implement value-based delivery care models for a wide range of women’s health services to better serve the health care needs of both Medicaid and commercial patient populations in the Nevada market.

“We are thrilled about this new partnership and the opportunities to partner with WHASN in building a new paradigm of care in women’s health. Nevada has one of the most innovative population health markets in the US and has therefore been a high priority market for Women’s Health USA for some time. Once we identified Nevada as a critical market for us, there was only one choice as to who the right partner was. With WHASN’s market leadership, strong reputation and considerable footprint we have the building blocks to construct a more effective and efficient physician-led, patient-centric, and data-driven women’s health care delivery model,” said Women’s Health USA CEO Goran Dragolovic.

John Martin, M.D., who founded WHASN in 2005 and is a practicing ObGyn within the group, spoke enthusiastically about the partnership and the potential it brings to deepen WHASN’s market presence and influence. “We really wanted a partner that shared the dual vision of leveraging the influence and efficiencies of a large group with the care delivery of small, private setting. After an exhaustive search, Women’s Health USA was the only choice that fit with our long-term growth plan.” Rebecca Herrero, M.D., president for the group added “By working with Women’s Health USA and their bench of experts, we’ll be able to move the ball forward more quickly on some of our key expansion initiatives.  Ultimately, our goal is to more deeply reach into our communities of women throughout Nevada and neighboring states to provide the most efficient and effective access to quality, patient-centric care.”

WHASN is a group of over 50 ObGyn physicians and 30 mid-level providers in the Southern Nevada area. The practice has 20 office locations in and around the Las Vegas metro area. The addition of this new partnership expands Women’s Health USA’s footprint as a premier national women’s health services company – now active in 7 states and serving more than 750,000 patients annually.

About Women’s Health USA

With a comprehensive suite of business management services, Women’s Health USA partners with ObGyn and other specialty women’s health practices across the United States. It has a 22-year history of implementing creative growth strategies supporting streamlined operational costs, payer alignment, merger and acquisition plans, ancillary services development, marketing and risk management services. Its unique partnership model enables physicians and physician groups to maintain their independence, while leveraging the resources of a national organization.

About Women’s Health Associates of Southern Nevada

Since 2009, WHASN has been committed to providing high quality healthcare for women in the Southern Nevada area. With 80 providers and 20 locations throughout southern Nevada, each office offers a full range of innovative techniques and technologies to promote and maintain good health practices through all phases of a woman’s life.